International Clinical Trial: Evaluation of direct-to-inject point-of-care HIV testing to facilitate rapid initiation of long-acting Cabotegravir for pre-exposure prophylaxis

Geneva, Nov. 3 -- International Clinical Trials Registry received information related to the study (ISRCTN74312863) titled 'Evaluation of direct-to-inject point-of-care HIV testing to facilitate rapid initiation of long-acting Cabotegravir for pre-exposure prophylaxis' on Oct. 23.

Study Type: Observational

Study Design: Mixed-methods prospective cohort study (Other)

Primary Sponsor: ViiV Healthcare (United Kingdom)

Condition: Describe and evaluate the implementation of a direct-to-inject HIV testing approach to facilitate rapid initiation of long-acting Cabotegravir for PrEP Other

Intervention: In this mixed-methods observational study, we will evaluate the implementation of a direct-to-inject HIV testing strategy for the rapid i...